North America Anemia Drugs Market Set to Reach USD 5.9 Billion by 2032 Amid Rising CKD and Cancer Cases
According to a new report from Intel Market Research, the North America Anemia Drugs Market was valued at USD 4,200 million in 2024 and is projected to grow from USD 4,410 million in 2025 to reach USD 5,900 million by 2032, growing at a CAGR of approximately 4.3% during the forecast period (2025–2032). This steady expansion is driven by the high and growing prevalence of chronic kidney...
0 Comments 0 Shares 11 Views 0 Reviews